STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

66 hedge funds and large institutions have $63.3M invested in Stemline Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.13M
2 +$764K
3 +$734K
4
Millennium Management
Millennium Management
New York
+$692K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$686K

Top Sellers

1 -$5.97M
2 -$4.2M
3 -$2.85M
4
VM
VHCP Management
New York
-$2M
5
OPPM
Opus Point Partners Management
New York
-$662K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$343K
27
$335K
28
$301K
29
$265K
30
$197K
31
$196K
32
$183K
33
$177K
34
$144K
35
$141K
36
$138K
37
$124K
38
$122K
39
$116K
40
$112K
41
$109K
42
$108K
43
$102K
44
$90K
45
$71K
46
$67K
47
$65K
48
$64K
49
$61K
50
$58K